The U.S. Food and Drug Administration and medical professionals have unhealthily close ties to drug firms, says this fascinating Boston Globe item on the new book Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial.
TAGS: pharmaceutical, investigations, investigative journalism, drugs
No comments:
Post a Comment